Clinical trial
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
NCT00142948 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00142948 |
|---|---|
| Title | Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts |
| Official title | Heroin Addiction Treatment: Naltrexone and Adrenergic Agents |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heroin Dependence |
| Intervention type | Drug |
| Interventions | Naltrexone, Placebo |
| Enrollment | 301 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Sep 2, 2005 |
| Last update posted | Oct 24, 2012 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: